The Beijing biotech has been set up to tap into the growing interest in macrocyclic peptides as an emerging treatment ...

The conflict in the Middle East is sending shockwaves through the global economy and disrupting global trade.

Chief among its criticisms is Novavax's failure to build sales of its protein-based COVID-19 vaccine Nuvaxovid/Covovax, a ...

France-based investment group Jeito Capital has closed its second fund, raking in €1 billion ($1.2 billion), which it claims ...

The EU has pledged €30 million ($35 million) in funding for medical countermeasures to antimicrobial resistance (AMR), ...

In modern drug discovery, successfully navigating the progress from molecular concept to viable therapeutic often hinges on ...

Preserve study integrity. Resist the temptation to bolt new exploratory endpoints midstream. If an additional endpoint is ...

LC: Manufacturability is the field's most critical near-term challenge, especially for ex vivo cell therapies. Encouragingly, ...

A legal bid to introduce a temporary block on remote access to the abortion pill mifepristone in the US, while the Trump ...

Shares in Abivax were tracking up this morning as a media report in France suggested a takeover by Eli Lilly – worth €15 billion ($17.5 billion) – could be on the cards. French newspaper La Lettre ...

Baldo discusses the ocular disease landscape, as well as Beacon’s work targeting X-linked retinitis pigmentosa (XLRP) and ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...